Cargando…
Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study
BACKGROUND: Behavioral treatments can augment the success of pharmacotherapy in smoking cessation. The aim of this study was to compare smoking quit rates between patients receiving individual counseling with their general practitioner during office visits or intensive counselling with behavioral su...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793508/ https://www.ncbi.nlm.nih.gov/pubmed/36575392 http://dx.doi.org/10.1186/s12875-022-01953-y |
_version_ | 1784859858830360576 |
---|---|
author | Yehoshua, Ilan Adler, Limor Hermoni, Sharon Alon Mizrahi Reuveni, Miri Bilitzky, Avital Oren, Keren Zacay, Galia |
author_facet | Yehoshua, Ilan Adler, Limor Hermoni, Sharon Alon Mizrahi Reuveni, Miri Bilitzky, Avital Oren, Keren Zacay, Galia |
author_sort | Yehoshua, Ilan |
collection | PubMed |
description | BACKGROUND: Behavioral treatments can augment the success of pharmacotherapy in smoking cessation. The aim of this study was to compare smoking quit rates between patients receiving individual counseling with their general practitioner during office visits or intensive counselling with behavioral support, both augmented by varenicline. METHODS: A nationwide retrospective cohort study conducted in a large Healthcare Maintenance Organization in Israel. We selected randomly patients who filled a prescription for varenicline and received either individual consulting by their general practitioner or intensive counselling with behavioural support, and asked them to answer a questionnaire. The outcome variables were smoking cessation 26–52 weeks following the beginning of treatment and satisfaction with the process. RESULTS: 870 patients were contacted and 604 agreed to participate (a response rate of 69%); 301 patients in the general practitioner group, 300 in the intensive counselling group and 3 were excluded due to missing date. The quit rate was 36.5% in the general practitioner group and 42.3% in the intensive counselling group (P = 0.147). In a logistic regression analysis, controlling for age, gender, socioeconomic status, ischemic heart disease, chronic obstructive pulmonary disease, pack years and duration of varenicline consumption, the adjusted OR for quitting in the general practitioner group was 0.79 (95% CI 0.56,1.13). The adjusted OR was higher in the group with the highest socioeconomic status at 2.06 (1.39,3.07) and a longer period of varenicline consumption at 1.30 (1.15,1.47). Age, gender and cigarette pack-years were not associated with quit rate. In the general practitioner group 68% were satisfied with the process, while 19% were not. In the intensive counselling group 64% were satisfied and 14% were not (P = 0.007). CONCLUSION: We did not detect a statistically significant difference in smoking quit rates, though there was a trend towards higher quit rates with intensive counselling. |
format | Online Article Text |
id | pubmed-9793508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97935082022-12-28 Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study Yehoshua, Ilan Adler, Limor Hermoni, Sharon Alon Mizrahi Reuveni, Miri Bilitzky, Avital Oren, Keren Zacay, Galia BMC Prim Care Research BACKGROUND: Behavioral treatments can augment the success of pharmacotherapy in smoking cessation. The aim of this study was to compare smoking quit rates between patients receiving individual counseling with their general practitioner during office visits or intensive counselling with behavioral support, both augmented by varenicline. METHODS: A nationwide retrospective cohort study conducted in a large Healthcare Maintenance Organization in Israel. We selected randomly patients who filled a prescription for varenicline and received either individual consulting by their general practitioner or intensive counselling with behavioural support, and asked them to answer a questionnaire. The outcome variables were smoking cessation 26–52 weeks following the beginning of treatment and satisfaction with the process. RESULTS: 870 patients were contacted and 604 agreed to participate (a response rate of 69%); 301 patients in the general practitioner group, 300 in the intensive counselling group and 3 were excluded due to missing date. The quit rate was 36.5% in the general practitioner group and 42.3% in the intensive counselling group (P = 0.147). In a logistic regression analysis, controlling for age, gender, socioeconomic status, ischemic heart disease, chronic obstructive pulmonary disease, pack years and duration of varenicline consumption, the adjusted OR for quitting in the general practitioner group was 0.79 (95% CI 0.56,1.13). The adjusted OR was higher in the group with the highest socioeconomic status at 2.06 (1.39,3.07) and a longer period of varenicline consumption at 1.30 (1.15,1.47). Age, gender and cigarette pack-years were not associated with quit rate. In the general practitioner group 68% were satisfied with the process, while 19% were not. In the intensive counselling group 64% were satisfied and 14% were not (P = 0.007). CONCLUSION: We did not detect a statistically significant difference in smoking quit rates, though there was a trend towards higher quit rates with intensive counselling. BioMed Central 2022-12-27 /pmc/articles/PMC9793508/ /pubmed/36575392 http://dx.doi.org/10.1186/s12875-022-01953-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Yehoshua, Ilan Adler, Limor Hermoni, Sharon Alon Mizrahi Reuveni, Miri Bilitzky, Avital Oren, Keren Zacay, Galia Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study |
title | Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study |
title_full | Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study |
title_fullStr | Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study |
title_full_unstemmed | Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study |
title_short | Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study |
title_sort | smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793508/ https://www.ncbi.nlm.nih.gov/pubmed/36575392 http://dx.doi.org/10.1186/s12875-022-01953-y |
work_keys_str_mv | AT yehoshuailan smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy AT adlerlimor smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy AT hermonisharonalon smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy AT mizrahireuvenimiri smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy AT bilitzkyavital smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy AT orenkeren smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy AT zacaygalia smokingquitratesamongpatientsreceivingpharmacotherapywhoreceivedgeneralpractitionercounsellingversusintensivecounsellingaretrospectivecohortstudy |